These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 4639347

  • 1. [Therapeutic effect of lactulose on shunt encephalopathy and blood ammonia concentration in cirrhosis patients].
    Eisenburg J, Krumpoch B, Grunst J, Weinzierl M, Munte A, Schmidt S, Magerl W, Schauer S.
    Fortschr Med; 1972 Aug 31; 90(24):837-48. PubMed ID: 4639347
    [No Abstract] [Full Text] [Related]

  • 2. Lactulose in the treatment of portal-systemic encephalopathy. Report of a symposium.
    Bircher J, Haemmerli UP, Williams R.
    Gastroenterology; 1970 Apr 31; 58(4):595-7. PubMed ID: 5438009
    [No Abstract] [Full Text] [Related]

  • 3. [Treatment of chronic portal-systemic encephalopathy with lactulose (synthetic disaccharide: one molecule of galactose and one of fructose)].
    Cassi E, Sala E, Beretta R, Colombo A, Cova L, Ezechieli S, Malacco E, Massarotti G, Pagani C.
    Clin Ter; 1972 Dec 31; 63(6):531-56. PubMed ID: 4656204
    [No Abstract] [Full Text] [Related]

  • 4. Lactulose treatment of hepatic encephalopathy in outpatients.
    Brown H, Trey C, McDermott WV.
    Arch Surg; 1971 Jan 31; 102(1):25-7. PubMed ID: 5538764
    [No Abstract] [Full Text] [Related]

  • 5. [Double blind study of lactulose in 8 patients with chronic hepatic encephalopathy after portocaval shunt].
    Germain L, Frexinos J, Louis A, Ribet A.
    Arch Fr Mal App Dig; 1973 Jun 31; 62(4):293-302. PubMed ID: 4594755
    [No Abstract] [Full Text] [Related]

  • 6. [Double blind study of lactulose in 8 patients with chronic hepatic encephalopathy after portocaval shunt].
    Germain L, Frexinos J, Louis A, Ribet A.
    Arch Fr Mal App Dig; 1973 Jun 31; 62(4):293-302. PubMed ID: 4594756
    [No Abstract] [Full Text] [Related]

  • 7. Encephalopathy after portacaval shunting managed with lactulose.
    Brown H, Trey C, McDermott WV.
    Am J Surg; 1970 Feb 31; 119(2):132-7. PubMed ID: 5440784
    [No Abstract] [Full Text] [Related]

  • 8. Lactulose treatment of hepatic encephalopathy: effects on carbohydrate metabolism and colonic hydrogen ion concentration.
    Trey C, Brown H, Goransky L, McDermott WV.
    Surg Forum; 1970 Feb 31; 21():355-6. PubMed ID: 4936990
    [No Abstract] [Full Text] [Related]

  • 9. Effect of portal ligation and of Eck's fistula on hepatic blood flow and concentration of blood ammonia.
    Aldrete JS, McIlrath DC, Hallenbeck GA.
    Surg Forum; 1966 Feb 31; 17():363-4. PubMed ID: 5920963
    [No Abstract] [Full Text] [Related]

  • 10. [Hyperammoniemia and porta-caval encephalopathy in patients with cirrhosis. Personal results of lactulose treatment].
    Butti A, Bianco S, Bergonzi P, Cagossi M, Civello IM, Borzone A, Nanni G, Pigliucci GM.
    Chir Patol Sper; 1975 Apr 31; 23(2):77-95. PubMed ID: 1140038
    [No Abstract] [Full Text] [Related]

  • 11. [Value of lactulose in the treatment of chronic porto-cave encephalopathy (20 cases)].
    Geffroy Y, Segrestin M, Geffroy PY.
    Therapeutique; 1970 Nov 31; 46(9):897-901. PubMed ID: 5486138
    [No Abstract] [Full Text] [Related]

  • 12. Lactulose treatment of chronic hepatoportal encephalopathy. A clinical and electroencephalographic study.
    Rorsman G, Sulg I.
    Acta Med Scand; 1970 May 31; 187(5):337-46. PubMed ID: 5526951
    [No Abstract] [Full Text] [Related]

  • 13. Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial.
    Elkington SG, Floch MH, Conn HO.
    N Engl J Med; 1969 Aug 21; 281(8):408-12. PubMed ID: 4894464
    [No Abstract] [Full Text] [Related]

  • 14. The mechanism of action of lactulose in portal-systemic encephalopathy. Non-ionic diffusion of ammonia in the canine colon.
    Bircher J, Haemmerli UP, Trabert E, Largiader F, Mocetti T.
    Rev Eur Etud Clin Biol; 1971 Apr 21; 16(4):352-7. PubMed ID: 5564547
    [No Abstract] [Full Text] [Related]

  • 15. Preoperative liver function tests correlated with encephalopathy after porta-caval anastomosis.
    Kardel T, Ramsöe K, Nörby Rasmussen S.
    Scand J Gastroenterol; 1975 Apr 21; 10(1):29-32. PubMed ID: 1079089
    [Abstract] [Full Text] [Related]

  • 16. [Effects of arginine malate in experimental and clinical hyperammonemia].
    Szãm I, Szentner J, Hegedüs-Wein I, Vass A.
    Int J Clin Pharmacol; 1972 Aug 21; 6(3):260-5. PubMed ID: 4648469
    [No Abstract] [Full Text] [Related]

  • 17. Some concepts on ammonia, porta-systemic shunts, and encephalopathy.
    Gips CH, Hindfelt B, Holmin T, Kardel T.
    Scand J Gastroenterol; 1973 Aug 21; 8(5):385-8. PubMed ID: 4584758
    [No Abstract] [Full Text] [Related]

  • 18. [On the diagnostic value of the brain wave pattern in hepato-portal encephalopathy: together with a clinical-statistical contribution to the question of neurologic and psychic changes in liver cirrhosis and portacaval anastomosis operations].
    Penin H.
    Fortschr Neurol Psychiatr Grenzgeb; 1967 Apr 21; 35(4):174-234. PubMed ID: 5182416
    [No Abstract] [Full Text] [Related]

  • 19. Some observations on the effects of treatment with lactulose on patients with chronic hepatic encephalopathy.
    Zeegen R, Drinkwater JE, Fenton JC, Vince A, Dawson AM.
    Q J Med; 1970 Apr 21; 39(154):245-63. PubMed ID: 5449591
    [No Abstract] [Full Text] [Related]

  • 20. Comparative study of basal arterial ammonemia and of orally-induced hyperammonemia in chronic portal systemic encephalopathy, treated with neomycin, lactulose, and an association of neomycin and lactulose.
    Pirotte J, Guffens JM, Devos J.
    Digestion; 1974 Apr 21; 10(6):435-44. PubMed ID: 4448315
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.